The results revealed that the mice administered the Tat‐Nrf2 peptide spent more time exploring novel objects compared to the mice treated with Tat‐Scr, demonstrating an improvement in declarative recognition memory after ischemic stroke (Figure 9I,J). The gene discussed is NFE2L2; the disease is ischemic stroke.